Health officials in the United States have urged doctors to be vigilant about a rare type of cancer that is likely to be linked to breast implants in women.
The fillings used for implantation or breast augmentation result in the emergence of a "large lymphocytic tumor," a type of blood cancer.
The cancer does not fall within breast cancer, and health experts say it affects white blood cells as well as weakening the immune system of women undergoing the procedure.
The US Food and Drug Administration said Wednesday in a letter to health providers that it wants to raise awareness about breast implants, The Insider reported.
The US Department of Health said that the number of women infected with this type of cancer reached 3,817, or one woman in every 30 thousand women who underwent a controversial operation.
Doctors say women who have undergone surgery should talk to their doctor if they notice anything unusual at the chest.
The doctor specializing in breast surgery, Diana Atai, that doctors are still ignorant of many things about the tumor cells large lymphocytes, which complicates the task of treatment.
The US Food and Drug Administration took note of the relationship between breast cancer and rare cancer in 2011, and a number of additional academic research were conducted.
By September 2018, the US Department of Health had received 457 special reports on breast and cancer operations, and eight deaths were recorded, most likely due to the consequences of the operation.
Experts estimate that only 1.5 percent of the world's 1.5 million women are breastfed every year, but it is also likely that women in some countries will not be aware of what happened.
